SCIENCE/TECHNOLOGY: Flu vaccines progress gradually

You must be signed in to read this analysis

Sign in Sign up to our newsletter

In this article

  • Role of vaccines
  • Adjuvants
  • Vaccines based on core or conserved proteins
  • Recombinant hemagglutinin (HA)
  • Virus-like particles (VLPs)
  • Virus vectors
  • Vaccines for complicating infections
  • Stockpiling vaccines
  • Antiviral treatment

What is this?

This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.